Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Axios on MSN
Longevity medicine's do-or-die moment
The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...
The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...
Xu and colleagues used partial OSKM reprogramming in aged mice to drive cell-type proportions of the subventricular zone to more youthful levels, which equates to qualified rejuvenation of a ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...
A team led by researchers at the University of Toronto has discovered that a group of cells located in the skin and other areas of the body, called neural crest stem cells, are the source of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results